Policy Committee

The HL7 Policy Advisory Committee (PAC) is a Board-appointed committee, evaluating HL7's role in the advocacy continuum. The PAC operates within the parameters identified in the Stance Document.

Work Group Meeting and Conference Call Agendas and Minutes

All agendas and minutes are posted to the HL7 Policy Committee Minutes page at http://www.hl7.org/Special/committees/policy/minutes.cfm

Current Activity

The Policy Advisory Committee is currently accepting input on those topics listed in the Active status to develop responses to various entities seeking input on proposed policy specific to health information technology and standards. Work Groups may post their responses to the wiki or submit comments to any member of the Policy Advisory Committee.

Backlog

• Pending/Potential
  • Canada
  • EU
    • EU Legal Framework on the Protection of Personal Data
    • PAC: eHealth Specification Platform
  • ONC
    • 2015 Edition NPRM
    • 10 Year Interoperability Roadmap
    • HIT-PC / HIT-SC testimonies
  • OCR
    • PAC: HIPAA Privacy & Security Regulations
  • South America
    • eHealth Agenda for Latin America
  • Other
    • World Bank?

• Active
  • Standards Maturity Measurement
    • Project Statement
    • Draft Maturity Measurement Survey
  • Standards Development Process
  • Interoperability Architecture
    • JASON 1 A Robust Health Data Infrastructure
    • JASON 2 Data for Individual Health
    • Emerging Technologies
    • Cloud Computing
  • Privacy/Security
    • Various resources
    • ISO/DTS Principles and data requirements for consent in the collection, use or disclosure of personal health information

• • Suggest to move to closed (too late to address):
    • PAC: FDASIA Report
    • PAC: A Future Perspective on Interoperability
    • PAC: Senate Letter with request for ideas
    • PAC: House Letter with request for ideas

• Closed
  • PAC: Modifications to Meaningful Use NPRM
  • PAC: 2015 Edition NPRM
  • PAC: IPPS
  • Health IT Strategic Planning
  • Advancing Interoperability and Health Information Exchange
  • MU 3 RFC
  • FDA AAMI
  • Clinical Quality for Meaningful Use Stage 3
  • Medicare Physician Fee Schedule - Quality Reporting Initiatives
  • FDA Request for Comments on Study Data Exchange Standards
  • PAC: 2014 Edition Test Scripts
  • AHRQ RFI on Quality Measurement
  • Incorporation of Patient Generated Data for Meaningful Use Stage 3
  • Interoperability Information of Digital Products and Services
  • NwHIN Governance
  • Federal Participation in Standards Development - Position Statement
  • Meaningful Use Stage 2 - May 7, 2012
  • Data Segmentation for Privacy Use Case Consensus Statement - Feb 3, 2012
  • Meaningful Use Stage 1
  • Policy News Room

Other Documents

• Workgroup Feedback on Stance Document
• See the Policy Advisory Committee Documents page at http://www.hl7.org/Special/committees/policy/docs.cfm for other documents and presentations.